IL6 and anemia (phenotype): The important role of inflammation in the pathogenesis of CKD anemia was demonstrated by the beneficial effects of anti-IL-6 therapy on anemia in hemodialysis-dependent patients, several of whom were able to discontinue erythropoiesis-stimulating agents altogether (52).